Add Yahoo as a preferred source to see more of our stories on Google. HeartBeam intends to initiate a limited launch of its ECG software device in Q1 2026. Image credit: YAKOBCHUK VIACHESLAV via ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

Boston, MA—October 22, 2025: ECG Management Consultants, a leading consulting firm to health systems and payers, today announced the addition of STAMP, a SaaS-based platform that enables payers to ...

The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias. According to a statement from the ...

HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an ECG-led diagnostics software company, today announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions. The partnership ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510(k) ...

With cases of arrhythmia and heart disease on the rise—thanks in large part to an aging global population—more tools and technologies are needed to speed up the process of diagnosing and beginning ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...

Wearable data is becoming more integrated into clinical practice, but there is one caveat, explains Sense2beat CEO Natalia Glazkova — those devices can be contaminated by a glut of data. Sense2beat is ...

REDWOOD CITY, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it is finalizing its FDA ...

HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for deployment in patients’ ...